Daxor Net Income 2010-2011 | DXR
Daxor net income from 2010 to 2011. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| Daxor Annual Net Income (Millions of US $) |
|
|---|---|
| 2011 | $-7 |
| 2010 | $5 |
| 2009 | $6 |
| Daxor Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2011-12-31 | $-1 |
| 2011-09-30 | $-4 |
| 2011-06-30 | $-0 |
| 2011-03-31 | $-1 |
| 2010-12-31 | $2 |
| 2010-09-30 | $3 |
| 2010-06-30 | $0 |
| 2010-03-31 | $-0 |
| 2009-12-31 | $-1 |
| 2009-09-30 | $3 |
| 2009-06-30 | $6 |
| 2009-03-31 | $-2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.046B | $0.000B |
| Daxor Corporation is a medical device manufacturing corporation with additional biotech services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $17.269B | 10.45 |
| Quest Diagnostics (DGX) | United States | $15.262B | 15.77 |
| DaVita (DVA) | United States | $11.791B | 14.65 |
| Chemed (CHE) | United States | $8.503B | 26.36 |
| Encompass Health (EHC) | United States | $8.333B | 21.45 |
| Elanco Animal Health (ELAN) | United States | $6.685B | 15.20 |
| Option Care Health (OPCH) | United States | $5.181B | 19.61 |
| RadNet (RDNT) | United States | $3.783B | 102.40 |
| Amedisys (AMED) | United States | $3.009B | 21.31 |
| LifeStance Health (LFST) | United States | $2.546B | 0.00 |
| Astrana Health (ASTH) | United States | $2.099B | 26.20 |
| Addus HomeCare (ADUS) | United States | $1.608B | 24.43 |
| U.S Physical Therapy (USPH) | United States | $1.585B | 41.09 |
| Pennant (PNTG) | United States | $0.642B | 37.54 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.448B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.343B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.026B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.019B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Ontrak (OTRK) | United States | $0.011B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.010B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.004B | 0.00 |